Improved understanding and management of COVID-19, a potentially life-threatening disease,
could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end…

Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…

Given the immune system's importance for cancer surveillance and treatment, we have
investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some …

Background The efficacy and safety profile of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) have not been definitively established in …

Person-to-person transmission of SARS-CoV-2 virus has triggered a global emergency
because of its potential to cause life-threatening Covid-19 disease. By comparison to …

In the version of this article initially published online, a statement of support was missing from
the Acknowledgements section. The correct ending of the fourth sentence of that section is …

Whereas pathogen-specific T and B cells are a primary focus of interest during infectious
disease, we have used COVID-19 to ask whether their emergence comes at a cost of broader B …

Here we consider how high‐content flow cytometric methodology at appropriate scale and
throughput rapidly provided meaningful biological data in our recent studies of COVID‐19, …

Upon binding with the chemokine CXCL12, the chemokine receptor CXCR4 has been
shown to promote breast cancer progression. This process, however, can be affected by the …

The molecular mechanisms of reduced frataxin (FXN) expression in Friedreich's ataxia (FRDA)
are linked to epigenetic modification of the FXN locus caused by the disease-associated …